| Nestin as a marker of cancer stem cells J Neradil, R Veselska Cancer science 106 (7), 803-811, 2015 | 292 | 2015 |
| Nestin expression in the cell lines derived from glioblastoma multiforme R Veselska, P Kuglik, P Cejpek, H Svachova, J Neradil, T Loja, ... BMC Cancer 6, 32, 2006 | 140 | 2006 |
| Nestin expression in human tumors and tumor cell lines. O Krupkova Jr, T Loja, I Zambo, R Veselska Neoplasma 57, 4, 2010 | 133 | 2010 |
| Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapies J Skoda, K Borankova, PJ Jansson, MLH Huang, R Veselska, ... Pharmacological research 139, 298-313, 2019 | 76 | 2019 |
| New mechanisms for an old drug; DHFR-and non-DHFR-mediated effects of methotrexate in cancer cells J Neradil, G Pavlasova, R Veselská Klin Onkol 25 (Suppl 2), 2S87-2S92, 2012 | 75 | 2012 |
| Effects of low-power laser irradiation on cell proliferation M Koutna, R Janisch, R Veselska Scripta Medica 76 (3), 163-172, 2003 | 71 | 2003 |
| Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines R Veselska, M Hermanova, T Loja, P Chlapek, I Zambo, K Vesely, ... BMC Cancer 8, 300, 2008 | 70 | 2008 |
| Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy V Dobrotkova, P Chlapek, P Mazanek, J Sterba, R Veselska BMC cancer 18, 1-13, 2018 | 60 | 2018 |
| Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the … P Mudry, O Slaby, J Neradil, J Soukalova, K Melicharkova, O Rohleder, ... BMC cancer 17, 1-7, 2017 | 59 | 2017 |
| Why differentiation therapy sometimes fails: molecular mechanisms of resistance to retinoids P Chlapek, V Slavikova, P Mazanek, J Sterba, R Veselska International journal of molecular sciences 19 (1), 132, 2018 | 55 | 2018 |
| Personalized treatment of H3K27M-mutant pediatric diffuse gliomas provides improved therapeutic opportunities J Gojo, Z Pavelka, D Zapletalova, MT Schmook, L Mayr, S Madlener, ... Frontiers in Oncology 9, 1436, 2020 | 51 | 2020 |
| Much more than you expected: the non-DHFR-mediated effects of methotrexate M Sramek, J Neradil, R Veselska Biochimica et Biophysica Acta (BBA)-General Subjects 1861 (3), 499-503, 2017 | 50 | 2017 |
| Screening of genomic imbalances in glioblastoma multiforme using high-resolution comparative genomic hybridization V Vranova, E Necesalova, P Kuglik, P Cejpek, M Pesakova, E Budinska, ... Oncology Reports 17 (2), 457-464, 2007 | 46 | 2007 |
| Repurposing tyrosine kinase inhibitors to overcome multidrug resistance in cancer: a focus on transporters and lysosomal sequestration M Krchniakova, J Skoda, J Neradil, P Chlapek, R Veselska International Journal of Molecular Sciences 21 (9), 3157, 2020 | 44 | 2020 |
| New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma S Gomes, L Raimundo, J Soares, JB Loureiro, M Leao, H Ramos, ... Cancer letters 446, 90-102, 2019 | 44 | 2019 |
| Co-expression of cancer stem cell markers corresponds to a pro-tumorigenic expression profile in pancreatic adenocarcinoma J Skoda, M Hermanova, T Loja, P Nemec, J Neradil, P Karasek, ... PloS one 11 (7), e0159255, 2016 | 43 | 2016 |
| Analysis of nuclear nestin localization in cell lines derived from neurogenic tumors O Krupkova, T Loja, M Redova, J Neradil, K Zitterbart, J Sterba, ... Tumor Biology 32, 631-639, 2011 | 42 | 2011 |
| UVC-protective effect of caffeic acid on normal and transformed human skin cells in vitro J Neradil, R Veselska, J Slanina Folia Biologica 49 (5), 197-202, 2003 | 42 | 2003 |
| Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice J Skoda, A Nunukova, T Loja, I Zambo, J Neradil, P Mudry, K Zitterbart, ... Tumor Biology 37, 9535-9548, 2016 | 39 | 2016 |
| CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines J Sana, I Zambo, J Skoda, J Neradil, P Chlapek, M Hermanova, P Mudry, ... Analytical Cellular Pathology 34 (6), 303-318, 2011 | 39 | 2011 |
Jan SkodaCancer Stem Cell Group, Laboratory of Tumor Biology - Faculty of Science, Masaryk UniversityVerified email at sci.muni.cz
